Sara Lightowlers

Chief Sustainability Officer's Clinical Fellow

Cambridgeshire County Council

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sara Lightowlers is the Chief Sustainability Officer's Clinical Fellow at the NHS Cambridgeshire and Peterborough Integrated Care Board in the UK. Her research spans various areas including sustainability in healthcare, radiotherapy frameworks, and the impacts of cancer treatment paradigms. Recently published articles encompass topics such as locoregional failure classification, breast cancer management strategies, and the intersection of cancer care and environmental sustainability.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Sarah Briggs

NIHR Clinical Lecturer

University of Oxford

UNITED KINGDOM

View details

Charlotte E Coles

Professor of Breast Cancer Clinical Oncology

University of Cambridge

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sara Lightowlers

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

659 A new sustainability framework for radiotherapy departments.

A unified workflow for classifying patterns of locoregional failure using radiotherapy treatment planning dose distributions.

Neoadjuvant Radiotherapy and Endocrine Therapy for Oestrogen Receptor Positive Breast Cancers: The Neo-RT Feasibility Study.

Abstract PO5-22-04: Genomic analysis of local recurrences following risk adapted breast radiotherapy in the IMPORT trials defines 'true recurrences' and 'new primaries'

Longitudinal Assessment of Tumor-Infiltrating Lymphocytes in Primary Breast Cancer Following Neoadjuvant Radiation Therapy.

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.

Cancer and climate change: the environmental impact of cancer care

OC-0291 IMPORT HIGH trial: Dose escalated simultaneous integrated boost radiotherapy in early breast cancer

When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management.

Definition of Tumor Bed Boost in Oncoplastic Breast Surgery: An Understanding and Approach.

Collaborators (2)

Sarah Briggs

Charlotte E Coles

Make your next move.